Signatures of malignant cells and novel therapeutic targets revealed by single-cell sequencing in lung adenocarcinoma.
Jiaqi LiangZhencong ChenYiwei HuangGuoshu BiYunyi BianXing JinHuan ZhangQihai SuiCheng ZhanQun WangPublished in: Cancer medicine (2022)
Our model can aid the analyses of single-cell sequencing data. CAPN8, IRX2, and SPINK13 may serve as novel targets of targeted and immune-based therapies in lung adenocarcinoma.